Cartesian Therapeutics
RNAC
#6732
Rank
A$0.71 B
Marketcap
$29.85
Share price
3.61%
Change (1 day)
-41.09%
Change (1 year)

P/S ratio for Cartesian Therapeutics (RNAC)

P/S ratio as of November 2024 (TTM): 8.75

According to Cartesian Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is -4.66. At the end of 2024 the company had a P/S ratio of 8.88.

P/S ratio history for Cartesian Therapeutics from 2016 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20248.88106.96%
20234.29175.01%
20221.56-67.05%
20214.74-75.99%
202019.7-35.88%
201930.8-53.52%
201866.2-93.75%
2017> 10002642.75%
201638.6